News

The company’s platform ECM Technology, an extracellular matrix biomaterial, is said to provide a natural bioscaffold that enables a patient’s own host cells to repopulate and repair damaged

The availability of the CLIA-waived InSure Quik F I T test is intended to help physicians increase patient compliance with an annual colorectal cancer screening test. In addition

C-QUR Edge V-Patch and C-QUR Lite V-Patch are designed to simplify umbilical, epigastric, trocar-site, and other small abdominal wall hernia repairs. C-QUR Edge V-Patch offers long-term protection from

The committed equity financing facility (CEFF) allows Jazz Pharmaceuticals to raise capital, at its discretion, to support the company’s commercial, product development and general corporate activities. Under the

The Court dismissed Johnson & Johnson’s lawsuit, found that the company’s NIR stent did not infringe one patent of Johnson & Johnson, and found that the other Johnson

The purpose of the offering is to enhance the company’s balance sheet. Certain officers and directors of Javelin will participate in this offering. The closing of the offering

The company reported net income of $33.7 million ($0.13 per diluted share) in the quarter ended March 31, 2008, compared with a net loss of $4.5 million ($0.02

Net loss for the three-month period ended March 31, 2008, was $6.7 million or $0.52 per share as compared to a net loss of $3.7 million or $0.31

Affymax’s total revenues for the quarter ended March 31, 2008 were $16.7 million compared to $7.3 million for the quarter ended March 31, 2007. The increase in revenue